Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32(5), pp. 915-920.
Full text not currently available from Enlighten.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McMurray, Professor John and Preiss, Dr David and Sattar, Professor Naveed |
Authors: | Preiss, D., Zetterstrand, S., McMurray, J., Ostergren, J., Michelson, E., Granger, C., Yusuf, S., Swedberg, K., Pfeffer, M., Gerstein, H., and Sattar, N. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences |
Journal Name: | Diabetes Care |
University Staff: Request a correction | Enlighten Editors: Update this record